Andrew Pollack

New York Times

Guest

Correspondent for the New York Times, covering the business and science of biotechnology

Andrew Pollack on KCRW

Mylan might or might not have good news for people who need EpiPens.

Drug-maker Mylan and its $300 "generic" EpiPen

Mylan might or might not have good news for people who need EpiPens.

from To the Point

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

When Drug Prices Skyrocket Overnight

Specialists who treat rare diseases are protesting gigantic increases in the prices of old and familiar drugs. The cost of one medicine jumped 5000 percent -- overnight.

from To the Point

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

The Ebola Drug

ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus.

from Press Play with Madeleine Brand

More from KCRW

Chuck Schumer unveiled a draft bill that would remove the plant from the federal list of controlled substances and expunge some federal cannabis-related criminal records.

from KCRW Features

This week on Left, Right & Center, it’s a special presentation of our companion show All The Presidents’ Lawyers.

from Left, Right & Center

The American federal government is probing its history of Native children who were taken from families and forced into boarding schools.

from KCRW Features

San Jose could become the first city in the U.S. to require gun owners to carry liability insurance. It’s also exploring the introduction of an annual fee for all gun owners.

from Press Play with Madeleine Brand

California voters will decide Gov. Gavin Newsom’s fate September 14. Lt. Gov.

from News Stories

Ken and Josh discuss the Avenatti trial(s), the DOJ’s decision on Mo Brooks, and how you get really, really wealthy people to show up for court.

from All the Presidents' Lawyers

Josh Barro speaks with Liz Bruenig and Ross Douthat about the U.S.

from Left, Right & Center

It’s an issue many communities across California are wrestling with: how to preserve historic buildings and landmarks that are part of their heritage without draining local government…

from Zócalo's Connecting California